scleritis
Information
- Disease name
- scleritis
- Disease ID
- DOID:13452
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT00075075 | Completed | Phase 1 | Infliximab to Treat Non-Infectious Scleritis | December 23, 2003 | September 6, 2007 |
| NCT00415506 | Completed | Phase 1/Phase 2 | Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation | January 2007 | March 2011 |
| NCT01517074 | Completed | Phase 1/Phase 2 | Sirolimus Injections for Autoimmune Scleritis | January 2012 | April 2014 |
| NCT01835132 | Completed | Phase 1/Phase 2 | Gevokizumab for Active Scleritis | March 2013 | February 2016 |
| NCT02764697 | Completed | Phase 4 | Study of H.P. ACTHAR Subcutaneous Gelatin (Gel)(Highly Purified Gel Injection) in Uveitis Patients | June 30, 2016 | December 20, 2016 |
| NCT03753893 | Completed | Ocular Manifestations in Rheumatic Diseases | May 1, 2013 | November 1, 2021 | |
| NCT03465111 | Recruiting | Phase 2 | A Clinical Study to Evaluate the Potential Role of ACTH Gel in Patients With Scleritis | January 1, 2019 | December 8, 2024 |
| NCT05200715 | Recruiting | AutoInflammatory Disease Alliance Registry (AIDA) | August 6, 2020 | August 6, 2030 | |
| NCT00367692 | Terminated | Phase 1 | Study Evaluating PSI-697 in Patients With Scleritis | September 2006 | April 2007 |
| NCT03660618 | Terminated | N/A | LSFG-SKIN, Laser Speckle Flowgraphy | May 23, 2017 | March 2, 2019 |
| NCT00539370 | Terminated | Human Samples and Data Repository | August 29, 2007 | August 19, 2022 | |
| NCT03580343 | Unknown status | Phase 2 | Tofacitinib for Inflammatory Eye Disease | April 4, 2019 | April 4, 2021 |
| NCT01613963 | Unknown status | Causes of Visual Loss in Retinal Disease | May 2012 | December 2012 |
- Disase is a (Disease Ontology)
- DOID:11343
- Cross Reference ID (Disease Ontology)
- GARD:12911
- Cross Reference ID (Disease Ontology)
- ICD10CM:H15.0
- Cross Reference ID (Disease Ontology)
- ICD9CM:379.00
- Cross Reference ID (Disease Ontology)
- MESH:D015423
- Cross Reference ID (Disease Ontology)
- NCI:C119046
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155201000
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0036416
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0100532
- ICD10 preferred id (Insert disease from ICD10)
- D0006055
- ICD10 class code (Insert disease from ICD10)
- H15.0
- MeSH unique ID (MeSH (Medical Subject Headings))
- D015423